Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin Lymphoma
帕博利珠单抗联合吉西他滨、长春瑞滨和脂质体阿霉素作为复发或难治性经典霍奇金淋巴瘤二线治疗的II期临床试验
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.21.01056
Moskowitz, Alison J; Shah, Gunjan; Schöder, Heiko; Ganesan, Nivetha; Drill, Esther; Hancock, Helen; Davey, Theresa; Perez, Leslie; Ryu, Sunyoung; Sohail, Samia; Santarosa, Alayna; Galasso, Natasha; Neuman, Rachel; Liotta, Brielle; Blouin, William; Kumar, Anita; Lahoud, Oscar; Batlevi, Connie L; Hamlin, Paul; Straus, David J; Rodriguez-Rivera, Ildefonso; Owens, Colette; Caron, Philip; Intlekofer, Andrew M; Hamilton, Audrey; Horwitz, Steven M; Falchi, Lorenzo; Joffe, Erel; Johnson, William; Lee, Christina; Palomba, M Lia; Noy, Ariela; Matasar, Matthew J; Pongas, Georgios; Salles, Gilles; Vardhana, Santosha; Sanin, Beatriz Wills; von Keudell, Gottfried; Yahalom, Joachim; Dogan, Ahmet; Zelenetz, Andrew D; Moskowitz, Craig H